Navigation Links
Prime Therapeutics Receives VIPPS Accreditation
Date:5/21/2008

ST. PAUL, Minn., May 21 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that it has received accreditation from the National Association of Boards of Pharmacy(R) (NABP(R)) through its Verified Internet Pharmacy Practice Sites(TM) (VIPPS(R)) Program.

Prime has met the VIPPS standards established by NABP in response to consumers' concerns regarding the safety of pharmacy practices on the Internet. VIPPS accreditation further authenticates Prime's Web-based pharmacy services as a reputable, accredited source of prescription drugs. PrimeMail(R), Prime's mail-service pharmacy, uses the Internet as a safe and convenient way for members to place orders and provides access to a number of useful pharmacy tools.

"Prime's top priority is ensuring that clients and members are continually receiving the highest quality care and service," said Keith McFalls, Vice President of PrimeMail. "VIPPS accreditation further demonstrates Prime's commitment to providing unmatched member safety and satisfaction while empowering clients with tools and information to aid in making more informed health care management decisions."

To become VIPPS accredited, a pharmacy must comply with the licensing and inspection requirements in each state they dispense pharmaceuticals. In addition, pharmacies that are VIPPS accredited have demonstrated to NABP compliance with VIPPS criteria, including: patient rights to privacy, authentication and security of prescription orders, adherence to a recognized quality assurance policy, and provision of meaningful consultation between patients and pharmacists.

Prime began the VIPPS accreditation process in April 2007 and received official accreditation confirmation on March 5, 2008. Prime's Web services provide a wide range of pharmacy benefit information and protects member confidentiality with password protections, encryption, firewalls and secure links. Member Web sites
'/>"/>

SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Primera Biosystems Raises $21 Million in Series B Private Round
2. Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
3. ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
4. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Nile Therapeutics Reports 2008 First Quarter Financial Results
6. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
7. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
8. Amicus Therapeutics Announces First Quarter 2008 Financial Results
9. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
11. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 The chemistry, taste, and health ... a new article published by the nonprofit American Botanical Council ... climate change and its effects on the phytochemical compounds in ... study conducted by Dr. Ahmed in the Yunnan ... and has implications for the future of medicinal botanicals. Dr. ...
(Date:9/15/2014)... septembre 2014 La deuxième édition annuelle ... (semaine internationale sur la sensibilisation au plasma) sera ... de la Plasma Protein Therapeutics Association ... l,IPAW vise à : , Sensibiliser ... collecte du plasma-aphérèse , Reconnaître la contribution ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Hydro ... ) announced today that it will be partnering ... CA ( http://www.proteaf.com ) for implementing its Shock ... value continuous processing. Continuous flow chemistry through ... chemical, pharmaceutical and petrochemical markets for decades. ...
(Date:9/14/2014)... Bacteria are particularly ingenious when it comes to survival ... from a hostile environment, for example during treatment with ... surrounded by a protective slime capsule consisting of sugar ... Universiteit Brussel have for the first time created a ... curli building blocks cross the bacterial cell wall, a ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... April 14 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ... financial results of the fiscal 2009 third quarter and ... the year-end results for its fiscal year 2009 now ... for the three-month period ended February 28, 2009 in ...
... April 13, 2009 Applied scientists at the Harvard ... with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, ... the direction of oscillation of the emitted radiation, known ... The innovation opens the door to a wide range ...
... Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., ... mL in PVC flexible containers to its existing Fluconazole ... is equivalent to Diflucan(R) by Pfizer. Fluconazole injection ... candidiasis, cryptococcal meningitis, and is also indicated for the ...
Cached Biology Technology:Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 2Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 3Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 4Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 5Scientists demonstrate laser with controlled polarization 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
(Date:9/15/2014)... life it,s not what comes to mind when you ... of Doncaster,s 310-million-year-old past, including a fossilised shark egg case, ... of the fossilised plants and creatures may even be new ... horseshoe crabs and some previously unrecorded seed pods are amongst ... formed within the coal and shale deposits in what is ...
(Date:9/15/2014)... balance between ridding the body of a dangerous virus ... appearing in The Journal of Experimental Medicine ... chronic infections in roughly three-quarters of infected people, putting ... cirrhosis and cancer. A few patients successfully eliminate infection, ... T cells. The protective effects of CD8 + ...
(Date:9/15/2014)... Ore. Amid conflicting reports about the need for ... analysis published today suggests that adequate levels of this ... the elderly, and women who are or may become ... is also important, researchers said, but often complicated by ... most difficult to obtain through diet alone. It has ...
Breaking Biology News(10 mins):'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3
... & IRRI (The International Rice Research Institute) today announced ... a new strategy that will galvanize agricultural research focused ... by a 2.55M USD grant to CAMBIA from The ... Initiative ?Biological Innovation for Open Society- is often called ...
... from researchers at Harvard Medical School and Massachusetts Institute ... Cancer Conference (ECCO) have shown for the first time ... , Nucleic acid ligands (referred to as aptamers) ... to target antigens with high specificity and affinity; analogous ...
... standard Internet protocol that checks errors made during ... to transform DNA microarray analysis, a common technology ... which blends experiment and computation, strengthens DNA microarray ... who is publishing his findings in the December ...
Cached Biology News:Open Source Biotechnology alliance for international agriculture 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 3Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 4Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool 2Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool 3
...
D.R. Harper (1993) • Includes: essential information on taxonomy, culture and safe handling of viruses, immunology, monoclonal antibodies, antivirals and vaccines....
... (1995) • This book is unique ... and molecular techniques currently used in ... analysis of virus-specific antibodies and clinical ... covering immunoassays, blotting and hybridization procedures, ...
Bovine Serum...
Biology Products: